NUCLEAR RECEPTOR NR4A2/NURR1 AS A THERAPEUTIC TARGET FOR NEUROTOXIC INJURY IN PARKINSON'S DISEASE

$1,199,032FY2022Defense Health AgencyDOD

Colorado State University, Fort Collins CO

Investigators